Developer docs
API playgroundTry for free, no card

Search company profiles

NeuroLex Laboratories

Full company profile

uuid000ahvq

Namestring
NeuroLex Laboratories
Websiteurl
neurolex.ai
Company typeenum
Private
Founded yearint
2016
Short descriptiontext

NeuroLex Laboratories was a Boston-based startup (founded 2016) that built voice-based screening tools to detect mental health conditions early and triage patients to specialists; it was acquired by Sonde Health.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
voice biomarker analytics, mental health screening, clinical voice analysis, healthcare voice AI, digital diagnostics
Industry4 codes
1Behavioral Health & Neurocognitive Therapeutics (Digital)
CodeHLACANAIPrimaryYes
2Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
CodeHLAAALAOPrimaryNo
3Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
4Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
CodeHLALAEAJPrimaryNo
NAICS code1 code
  • Offices of Physicians, Mental Health Specialists621112
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Clinical Voice Diagnostics
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

NeuroLex Laboratories develops voice-based diagnostic technology that analyzes vocal biomarkers to detect mental health conditions early and refer patients to specialists faster. The company's offering targets healthcare providers with voice-user interface tools for patient care, physician productivity enhancement, and remote patient communication.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Voice-Based Mental Health Screening Tool
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
1Aural Analytics
TypeDirect peer
Description

Aural Analytics develops speech analytics and digital biomarkers for neurological and respiratory disease detection. Comparable to NeuroLex in using voice signals as digital biomarkers for clinical assessment.

2Kintsugi
TypeDirect peer
Description

Kintsugi applies voice biomarker AI to detect depression and other mental health conditions from short voice clips. Closely comparable to NeuroLex in technology, use case, and target customer base.

3Cogito Corporation
TypeBroad incumbent
Description

Cogito applies voice and conversation AI to analyze behavioral and emotional signals, primarily in call center and enterprise settings with extensions into healthcare. Comparable to NeuroLex in voice-driven behavioral analysis, though broader in commercial application.

4Sonde Health
TypeDirect peer
Description

Sonde Health acquired NeuroLex Laboratories and builds voice-based mental and respiratory health biomarker platforms. It is the most directly comparable peer as both organizations target voice-driven detection of mental health conditions for clinical and consumer use.

5Winterlight Labs
TypeDirect peer
Description

Winterlight Labs builds speech-based digital biomarkers for cognitive and mental health conditions, including dementia and depression. Comparable to NeuroLex in using voice analytics for clinical-grade mental and neurological health assessments.

6Ellipsis Health
TypeDirect peer
Description

Ellipsis Health develops AI-driven vocal biomarker technology to detect and manage depression and anxiety. It is a direct competitor to NeuroLex in the voice-based mental health screening category.

7VoiceSense
TypeDirect peer
Description

VoiceSense provides voice-based predictive analytics for behavioral and health-related insights. Comparable to NeuroLex in leveraging vocal characteristics as health and behavioral biomarkers.

8Affectiva (Smart Eye)
TypeBroad incumbent
Description

Affectiva, now part of Smart Eye, builds emotion AI from voice and facial signals for automotive, media, and healthcare applications. Comparable to NeuroLex as an established voice-based emotion and behavioral analytics player with a wider portfolio.

9Behavioral Signals
TypeDirect peer
Description

Behavioral Signals offers voice emotion AI and analytics for contact centers and healthcare applications. Comparable to NeuroLex in applying voice signal analysis to mental and behavioral health use cases.

10Modality.ai
TypeDirect peer
Description

Modality.ai provides AI-driven voice and conversational analysis tools for neurological and psychiatric assessment. Comparable to NeuroLex in deploying voice AI for mental health detection and clinical workflow integration.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NeuroLex Laboratories

Clinical Voice Diagnosticsneurolex.ai

NeuroLex Laboratories was a Boston-based startup (founded 2016) that built voice-based screening tools to detect mental health conditions early and triage patients to specialists; it was acquired by Sonde Health.

NeuroLex Laboratories firmographics

Firmographics
Name
NeuroLex Laboratories
Website
https://neurolex.ai
Company type
Private
Founded year
2016
Headcount range
1–10 employees
Short description
NeuroLex Laboratories was a Boston-based startup (founded 2016) that built voice-based screening tools to detect mental health conditions early and triage patients to specialists; it was acquired by Sonde Health.
Ownership category
akta.pro rank

NeuroLex Laboratories industry classification

Industry
Product category
Clinical Voice Diagnostics
NAICS
Offices of Physicians, Mental Health Specialists (621112)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
akta.pro secondary industries
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)

Keywords

  • Voice biomarker analytics
  • Mental health screening
  • Clinical voice analysis
  • Healthcare voice AI
  • Digital diagnostics

Where NeuroLex Laboratories is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

NeuroLex Laboratories business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

NeuroLex Laboratories product offering

Product offering

Core offering

NeuroLex Laboratories develops voice-based diagnostic technology that analyzes vocal biomarkers to detect mental health conditions early and refer patients to specialists faster. The company's offering targets healthcare providers with voice-user interface tools for patient care, physician productivity enhancement, and remote patient communication.

Differentiator

Problem solved

Functional benefit

Products and services

  • Voice-Based Mental Health Screening Tool

Companies that use NeuroLex Laboratories

Customer profile

Segments1 record

Ideal customer profiles1 record

NeuroLex Laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

NeuroLex Laboratories partnerships and signals

Strategic signal

Scale indicators1 record

NeuroLex Laboratories competitors and assessment

Company assessment

Direct peers

  • Aural Analytics: Aural Analytics develops speech analytics and digital biomarkers for neurological and respiratory disease detection. Comparable to NeuroLex in using voice signals as digital biomarkers for clinical assessment.
  • Kintsugi: Kintsugi applies voice biomarker AI to detect depression and other mental health conditions from short voice clips. Closely comparable to NeuroLex in technology, use case, and target customer base.
  • Sonde Health: Sonde Health acquired NeuroLex Laboratories and builds voice-based mental and respiratory health biomarker platforms. It is the most directly comparable peer as both organizations target voice-driven detection of mental health conditions for clinical and consumer use.
  • Winterlight Labs: Winterlight Labs builds speech-based digital biomarkers for cognitive and mental health conditions, including dementia and depression. Comparable to NeuroLex in using voice analytics for clinical-grade mental and neurological health assessments.
  • Ellipsis Health: Ellipsis Health develops AI-driven vocal biomarker technology to detect and manage depression and anxiety. It is a direct competitor to NeuroLex in the voice-based mental health screening category.
  • VoiceSense: VoiceSense provides voice-based predictive analytics for behavioral and health-related insights. Comparable to NeuroLex in leveraging vocal characteristics as health and behavioral biomarkers.
  • Behavioral Signals: Behavioral Signals offers voice emotion AI and analytics for contact centers and healthcare applications. Comparable to NeuroLex in applying voice signal analysis to mental and behavioral health use cases.
  • Modality.ai: Modality.ai provides AI-driven voice and conversational analysis tools for neurological and psychiatric assessment. Comparable to NeuroLex in deploying voice AI for mental health detection and clinical workflow integration.

Broad incumbents

  • Cogito Corporation: Cogito applies voice and conversation AI to analyze behavioral and emotional signals, primarily in call center and enterprise settings with extensions into healthcare. Comparable to NeuroLex in voice-driven behavioral analysis, though broader in commercial application.
  • Affectiva (Smart Eye): Affectiva, now part of Smart Eye, builds emotion AI from voice and facial signals for automotive, media, and healthcare applications. Comparable to NeuroLex as an established voice-based emotion and behavioral analytics player with a wider portfolio.

Market position

Customer concentration

NeuroLex Laboratories social profiles

Digital presence

NeuroLex Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NeuroLex Laboratories leadership team

Management profile

Number of profiles

NeuroLex Laboratories funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NeuroLex Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroLex Laboratories

What does NeuroLex Laboratories do?

NeuroLex Laboratories develops voice-based diagnostic technology that analyzes vocal biomarkers to detect mental health conditions early and refer patients to specialists faster. The company's offering targets healthcare providers with voice-user interface tools for patient care, physician productivity enhancement, and remote patient communication.

When was NeuroLex Laboratories founded?

NeuroLex Laboratories was founded in 2016. It employs 1 to 10 people.

Where is NeuroLex Laboratories based?

NeuroLex Laboratories is headquartered in Boston, United States, in the North America region.

Who are NeuroLex Laboratories's main competitors?

Direct peers on record are Aural Analytics, Kintsugi, Sonde Health, Winterlight Labs, Ellipsis Health, VoiceSense, Behavioral Signals and Modality.ai. Broad incumbents are Cogito Corporation and Affectiva (Smart Eye).

Does NeuroLex Laboratories have an API?

No public API is recorded for NeuroLex Laboratories.

What industry is NeuroLex Laboratories in?

NeuroLex Laboratories's product category is Clinical Voice Diagnostics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays). Its NAICS code is 621112 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales